These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 11386629)

  • 21. A Bayesian approach for incorporating economic factors in sample size design for clinical trials of individual drugs and portfolios of drugs.
    Patel NR; Ankolekar S
    Stat Med; 2007 Nov; 26(27):4976-88. PubMed ID: 17579924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Bayesian approach on sample size calculation for comparing means.
    Wang H; Chow SC; Chen M
    J Biopharm Stat; 2005; 15(5):799-807. PubMed ID: 16078386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Empirical Bayes models of Poisson clinical trials and sample size determination.
    Zaslavsky BG
    Pharm Stat; 2010; 9(2):133-41. PubMed ID: 19513984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adaptive Bayesian randomized trials: realizing their potential.
    Pullenayegum EM
    J Bone Joint Surg Am; 2012 Jul; 94 Suppl 1():29-33. PubMed ID: 22810444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using covariates to reduce uncertainty in the economic evaluation of clinical trial data.
    Vázquez-Polo FJ; Negrín Hernández MA; López-Valcárcel BG
    Health Econ; 2005 Jun; 14(6):545-57. PubMed ID: 15497202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Bayesian analysis of pharmacoeconomic data from a clinical trial on schizophrenia.
    Petit C; Maccario J
    Stat Med; 2003 Mar; 22(6):1025-39. PubMed ID: 12627416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal sample size determinations from an industry perspective based on the expected value of information.
    Willan AR
    Clin Trials; 2008; 5(6):587-94. PubMed ID: 19029207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Practical midcourse sample size modification in clinical trials.
    Proschan MA; Liu Q; Hunsberger S
    Control Clin Trials; 2003 Feb; 24(1):4-15. PubMed ID: 12559638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Robust Bayesian sample size determination in clinical trials.
    Brutti P; De Santis F; Gubbiotti S
    Stat Med; 2008 Jun; 27(13):2290-306. PubMed ID: 18205170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bayesian statistical methods in public health and medicine.
    Etzioni RD; Kadane JB
    Annu Rev Public Health; 1995; 16():23-41. PubMed ID: 7639872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sample size estimation in single-arm clinical trials with multiple testing under frequentist and Bayesian approaches.
    Zaslavsky BG; Scott J
    J Biopharm Stat; 2012; 22(4):819-35. PubMed ID: 22651117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Bayesian model averaging approach for cost-effectiveness analyses.
    Conigliani C; Tancredi A
    Health Econ; 2009 Jul; 18(7):807-21. PubMed ID: 18792078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of prior information for Bayesian evaluation of bridging studies.
    Hsiao CF; Hsu YY; Tsou HH; Liu JP
    J Biopharm Stat; 2007; 17(1):109-21. PubMed ID: 17219758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innovative approaches to clinical development and trial design.
    Orloff JJ; Stanski D
    Ann Ist Super Sanita; 2011; 47(1):8-13. PubMed ID: 21430331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A decision theoretic approach to sample size determination in clinical trials.
    Gittins JC; Pezeshk H
    J Biopharm Stat; 2002 Nov; 12(4):535-51. PubMed ID: 12477073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bayesian sample-size determination for two independent Poisson rates.
    Hand AL; Stamey JD; Young DM
    Comput Methods Programs Biomed; 2011 Nov; 104(2):271-7. PubMed ID: 21146897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimal sample size for a series of pilot trials of new agents.
    Yao TJ; Begg CB; Livingston PO
    Biometrics; 1996 Sep; 52(3):992-1001. PubMed ID: 8805764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bayesian methods for design and analysis of safety trials.
    Price KL; Xia HA; Lakshminarayanan M; Madigan D; Manner D; Scott J; Stamey JD; Thompson L
    Pharm Stat; 2014; 13(1):13-24. PubMed ID: 23897858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Large-sample Bayesian posterior distributions for probabilistic sensitivity analysis.
    Hazen GB; Huang M
    Med Decis Making; 2006; 26(5):512-34. PubMed ID: 16997928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness analysis when the WTA is greater than the WTP.
    Willan AR; O'Brien BJ; Leyva RA
    Stat Med; 2001 Nov; 20(21):3251-9. PubMed ID: 11746316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.